New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients?

Lung cancer is one of the kinds of cancer that is most likely to spread to the brain. Approximately 20 percent of lung cancer patients develop brain metastases. And roughly 10 to 20 percent of people ...

An analysis of more than 250,000 older adults diagnosed with metastatic non-small cell lung cancer showed only about half ...

Outcomes of patients with concurrent chronic lymphocytic leukemia and non-small cell lung carcinoma. Circulating tumor DNA as a prognostic biomarker for long-term survival in de-novo oligometastatic ...

About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in ...

Deaths from cancer have fallen dramatically. They’ve dropped by 34% over the past three decades — largely thanks to better treatments, earlier detection, and fewer people smoking. But cancer ...

Breast metastasis from lung cancer is an uncommon yet clinically significant phenomenon that poses unique diagnostic and therapeutic challenges. Unlike primary breast carcinoma, these metastatic ...

Leuven, 2 January 2024 – Researchers from the lab of Prof. Sarah-Maria Fendt (VIB-KU Leuven) and colleagues have uncovered that the availability of the amino acid aspartate is one reason why the lung ...